Toxic Peptides From Snakes, Insects, and Microbes Share a Common Cell-Killing Structure | Research

The takeaway

Despite coming from phylogenetically distant species, cytolytic peptides converge on a common structural motif: a cationic site flanked by a hydrophobic surface.

Convergent evolution
Same membrane-disrupting motif in species separated by hundreds of millions of years

What the researchers found

Cytolytic peptides from diverse species converge on a common structural motif: a cationic site flanked by a hydrophobic surface. This motif is necessary and sufficient for membrane-disrupting activity.

Why it matters

Identifying the common structural requirement for cell-killing activity provides a blueprint for designing new antibacterial and anticancer peptides.

How the study worked

Comparative sequence analysis of cytolytic peptides from multiple species, supported by evidence from synthetic analogs and chemical modification studies.

What this study cannot tell us

This is a sequence comparison study. The proposed structural motif needs experimental validation in each case. Not all peptides with this motif may be cytolytic.

How to read the evidence

Preliminary — comparative sequence analysis review with supporting experimental evidence.

When this study was published

Published in 1989 — identified the universal cytolytic motif guiding peptide drug design.

The bigger picture

Understanding the universal structure for membrane disruption enables rational design of antimicrobial peptides and cancer-killing agents. Nature has converged on one solution to punching holes in cell membranes.

Questions still open

Can the common motif be minimized for drug design?
Could selectivity for bacterial vs human membranes be engineered?

Common questions

How do these peptides kill cells?

They insert their hydrophobic surface into the cell membrane while their charged region destabilizes the membrane structure, creating pores that cause the cell to leak and die.

Can this be used for medicine?

Yes — antimicrobial peptides based on this motif are being designed to kill drug-resistant bacteria. The challenge is making them selective for bacterial membranes over human cells.

Read the original research

A common cytolytic region in myotoxins, hemolysins, cardiotoxins and antibacterial peptides.

International journal of peptide and protein research, 34(4), 277-86

View on PubMed ↗

Citation

Kini, R M; Evans, H J. (1989). A common cytolytic region in myotoxins, hemolysins, cardiotoxins and antibacterial peptides.. International journal of peptide and protein research, 34(4), 277-86.